+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ophthalmic Suspensions"

Conjunctivitis Treatment Global Market Report 2024 - Product Thumbnail Image

Conjunctivitis Treatment Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Optic Nerve Disorders Treatment Global Market Report 2024 - Product Thumbnail Image

Optic Nerve Disorders Treatment Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
From
From
From
From
From
From
From
From
Macular Edema - Pipeline Review, H1 2020 - Product Thumbnail Image

Macular Edema - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 92 Pages
  • Global
From
  • 16 Results (Page 1 of 1)
Loading Indicator

Ophthalmic Suspensions are a type of eye drop used to treat a variety of eye conditions. These suspensions are typically composed of a combination of active ingredients, such as antibiotics, steroids, and anti-inflammatory agents, suspended in a liquid vehicle. Ophthalmic Suspensions are used to treat a variety of conditions, including conjunctivitis, blepharitis, and dry eye. They are also used to treat glaucoma, cataracts, and other eye diseases. The Ophthalmic Suspensions market is a rapidly growing segment of the Optical industry. This market is driven by the increasing prevalence of eye diseases, the growing demand for effective treatments, and the development of new technologies. The market is also driven by the increasing availability of generic and over-the-counter products. Some of the major companies in the Ophthalmic Suspensions market include Allergan, Bausch + Lomb, Novartis, Pfizer, and Santen Pharmaceuticals. Show Less Read more